Eupraxia Pharmaceuticals Ratios (2022-2026) | EPRX

Ratios Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Net Margin (Quarter) 3,087.03%-713.70%-1,881.16%
FCF Margin (Quarter) 3,557.67%-710.57%-1,621.74%
Efficiency
Assets Average (Quarter) 28.45M30.81M17.67M22.65M32.09M26.41M57.97M89.25M115.75M
Invested Capital (Quarter) 0.08M10.34M
Leverage & Solvency
Debt Ratio (Quarter) 0.010.510.000.00
Dividends & Payouts
FCF Payout Ratio (Quarter) -3.05-0.12-1.71-5.861.641.44-4.710.94-15.56
Valuation
Enterprise Value (Quarter) -8.01M-20.67M-37.35M-24.81M-10.20M-34.67M-29.03M-21.34M-90.54M-82.16M-140.48M
Return Ratios
Return on Sales (Quarter) 0.31%-0.07%-0.19%
Return on Assets (Quarter) 0.00%0.00%-0.01%-0.01%0.00%-0.01%0.00%0.00%0.00%